Prospecto:Information for the User
Elontril 300 mg Modified Release Tablets
bupropion hydrochloride
Read this prospectus carefully before starting to take this medication, as it contains important information for you.
Elontril is a prescription medication prescribed by your doctorfor the treatment of depression. It is believed to act on certain substances in the brain callednoradrenalineanddopamine.
If you are in any of these situations,inform your doctor immediately anddo not take Elontril.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Elontril.
Brugada Syndrome
- if you have a condition called Brugada Syndrome (a rare inherited disorder that affects heart rhythm) or if you have had a heart attack or sudden death in your family.
Children and adolescents
Elontril is not recommended for the treatment of children under 18 years of age.
In patients under 18 years of age, there is a higher risk of suicidal thoughts and attempts when taking antidepressants.
Adults
Inform your doctor before starting to take Elontril:
Elontril has been observed to cause seizures (convulsions) in approximately 1 in 10,000 people. This adverse effect is more likely to occur in people who are in the situations mentioned above. If you have a seizure while taking Elontril,stop taking Elontril. Do not take it again and see your doctor.
If you are in any of the situations mentioned above,consult your doctor before taking Elontril, who may decide to monitor you more closely or recommend another treatment.
Suicidal thoughts and worsening of depression
If you are depressed, you may have thoughts of harming yourself or suicide. These may increase at the beginning of treatment with antidepressants, as all these medicines take time to work, usually two weeks, but sometimes longer.
It is likely that this will happen:
If you have thoughts of harming yourself or suicide at any time,see your doctor or go to the hospital immediately.
It may be helpful for you to explain to a family member or close friendthat you are depressed or have anxiety disorders, and ask them to read this leaflet. You can also ask them to tell you if they think your depression or anxiety is getting worse, or if they are concerned about changes in your behavior.
Other medicines and Elontril
Stop taking Elontril and inform your doctorif you are taking or have taken antidepressant medicines calledmonoamine oxidase inhibitors(MAOIs) in the last two weeks (see also section 2 “Do not take Elontril”).
Inform your doctor or pharmacist that you are using, have used recently, or may need to use any other medicine,vitamins or herbal remedies, even those bought without a prescription. Your doctor may change your Elontril dose or suggest a change in other medicines.
Some medicines interact with Elontril.Some of them may increase the risk of seizures or convulsions, and others may increase the risk of other adverse effects. The following are some examples, although the list is not complete.
It may increase the risk of seizures
If you are in any of these situations,inform your doctor immediately before taking Elontril. Your doctor will assess the risks and benefits of you taking Elontril.
It may increase the risk of other adverse effects
If you are in any of these situations,inform your doctor immediately before taking Elontril.
Elontril may be less effective
Inform your doctor if you are taking any of these medicines.Your doctor will check if Elontril is working properly for you. You may need to increase your dose or change to another treatment for your depression.Do not increaseyour Elontril dose unless your doctor advises you to, as this may increase the risk of adverse effects, including seizures.
Elontril may make other medicines less effective
Inform your doctor if you are in this situation.You may need to change your treatment for depression.
Inform your doctor if you are in this situation.Your doctor may consider adjusting your digoxin dose.
Use of Elontril and alcohol
Alcohol may affect the way Elontril works and, when taken together, rarely may affect your nerves or mental state. Some people have noticed that they are more sensitive to alcohol during treatment with Elontril. Your doctor may recommend that you do not drink alcohol (beer, wine, spirits) or drink very small amounts while taking Elontril. If you currently drink a lot of alcohol, do not stop suddenly, as you may be at risk of having a seizure.
Consult your doctor about alcohol consumptionbefore starting your treatment with Elontril.
Effect on urine tests
Elontril may interfere with some urine tests used to detect other medicines or substances. If you need a urine test, inform your doctor or the hospital that you are taking Elontril.
Pregnancy and breastfeeding
Do not take Elontril if you are pregnant, think you may be pregnant, or plan to become pregnant unless your doctor prescribes it. Consult your doctor or pharmacist before using this medicine. Some studies, not all, have reported an increased risk of birth defects, particularly heart defects, in babies whose mothers were taking Elontril. It is not known if this is due to the use of Elontril.
The components of Elontril may pass into breast milk. Consult your doctor or pharmacist before taking Elontril.
Driving and operating machinery
Do not drive or operate tools or machinery if Elontril makes you dizzy or drowsy.
Follow exactly the administration instructions of this medication indicated by your doctor or pharmacist. The recommended doses are listed below, but your doctor will advise you on the appropriate dose for you. In case of doubt, consult your doctor or pharmacist again.
You may need to wait a while before you start noticing an improvement.The medication takes time to exert its full effect, which can be weeks or months. When you start feeling better, your doctor will be able to advise you to continue your treatment with Elontril to prevent depression from recurring.
What dose to take
The usual recommended dose in adults isone150 mg tablet per day.
If after several weeks you do not start feeling better,your doctor may increase the dose to 300 mg per day.
Take the Elontril tablets in the morning. Do not take Elontril more than once a day.
The tablet is covered with a film that releases the medication slowly in your body. Sometimes you may notice that a kind of tablet appears in your stool. This is the empty coating film that has passed through your intestine.
Swallow the tablets whole.Do not chew, crush, or divide the tablets, as this may increase the risk of overdose due to the rapid release of the medication in your body, increasing the likelihood of adverse effects, including seizures.
Some people may maintain a dose of one 150 mg tabletper day throughout treatment. Your doctor may prescribe this dose in patients with liver or kidney problems.
Treatment duration
Consult with your doctor, who will advise you on the duration of treatment with Elontril.You may need several weeks or months to notice any improvement. Keep your doctor informed regularly about your symptoms so they can decide on the duration of treatment. Although you may start feeling better, your doctor may recommend continuing treatment with Elontril to prevent depression symptoms from recurring.
If you take more Elontril than you should
In case of overdose or accidental ingestion,consult your doctor or pharmacist immediatelyor go to the emergency room or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
If you take more tablets than indicated by your doctor, you may increase the risk of experiencing seizures or convulsions.
If you forget to take Elontril
If you forget to take a dose, wait and take the next dose at the usual time.
Do not take a double dose to compensatefor the missed doses.
If you interrupt treatment with Elontril
Do notinterrupt treatment with Elontril or reduce the dose without consulting your doctor first.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Severe side effects
Seizures or convulsions
About 1 in 1,000 people who take Elontril have a risk of having a seizure (a fit or convulsion). This risk is higher if you take more tablets than you should, if you are taking certain medicines, or if you have a higher than usual risk of having fits. If you have any doubts, ask your doctor.
Allergic reactions
Some people may have allergic reactions to Elontril, including:
Allergic reactions can last for a long time.If your doctor prescribes a medicine for this, make sure to complete the treatment.
Systemic lupus erythematosus or worsening of lupus symptoms
Unknown frequency: the frequency cannot be estimated with the available data from people taking Elontril. Lupus is an autoimmune disorder that affects the skin and other organs.
Generalized Acute Exanthematous Pustulosis (GPE)
Unknown frequency: the frequency cannot be estimated with the available data from people taking Elontril.
The symptoms of GPE include a rash with pus-filled blisters.
Other side effects
Very common side effects
Thesemay affect more than 1 in 10 people:
Common side effects
Thesemay affectup to 1 in 10 people:
Uncommon side effects
Thesemay affectup to 1 in 100 people:
Rare side effects
Thesemay affectup to 1 in 10,000 people:
Very rare side effects
Thesemay affectup to 1 in 100,000 people:
Unknown frequency
Other side effects have occurred in a small number of people, but the exact frequency is unknown:
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Vigilance of Medicines for Human Use:www.notificaRAM.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not usethis medicationafter the expiration date that appears on the packaging. The expiration date is the last day of the month indicated.
Store in the original packaging to protect it from moisture and light. The bottle contains a small sealed container with activated charcoal and silica gel to keep the tablets dry. Keep the container inside the bottle. Do not ingest.
Medications should not be disposed of through drains or in the trash. Dispose of the packaging and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. By doing so, you will help protect the environment.
The active ingredient is bupropion hydrochloride. Each tablet contains 300 mg of bupropion hydrochloride.
The other components are:
Tablet core: Polysorbate (vinyl alcohol), dibehenate of glycerol.
Coating: Ethylcellulose, povidone K-90, macrogol 1450, dispersion of copolymer of methacrylic acid and ethyl acrylate, silicon dioxide, triethyl citrate.
Printing ink: Shellac Glaze, iron oxide black (E172) and ammonium hydroxide.
Appearance of the product and contents of the packaging
Elontril 300 mg tablets are white-cream to light yellow, round, with one face marked with “GS 5YZ 300” in black ink and the other smooth. They are available in white polyethylene bottles containing 7, 30, 90 or 90 (3 x 30) tablets.
Only some packaging sizes may be marketed.
Marketing authorization holder and responsible manufacturer
Marketing authorization holder | GlaxoSmithKline, S.A. P.T.M. C/ Severo Ochoa, 2 28760 Tres Cantos (Madrid) Tel: +34 900 202 700 |
Responsible manufacturer | Glaxo Wellcome S.A. Avenida de Extremadura, 3 09400 Aranda de Duero, Burgos Spain |
This medicine is authorized in the member states of the European Economic Area with the following names:
Wellbutrin XR: Austria, Belgium, Cyprus, Greece, Luxembourg, Malta, Poland, Portugal, Slovenia, Netherlands.
Wellbutrin: Italy.
Elontril: Czech Republic, Estonia, Germany, Hungary, Italy, Lithuania, Portugal, Romania, Slovakia, Spain, Netherlands.
Wellbutrin Retard: Iceland, Norway.
Voxra: Finland, Sweden.
Last review date of this prospectus: March 2024
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.